Bryan P. Yan

8.6k total citations
208 papers, 5.0k citations indexed

About

Bryan P. Yan is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bryan P. Yan has authored 208 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Cardiology and Cardiovascular Medicine, 84 papers in Surgery and 35 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bryan P. Yan's work include Coronary Interventions and Diagnostics (44 papers), Acute Myocardial Infarction Research (32 papers) and Cardiac Arrhythmias and Treatments (29 papers). Bryan P. Yan is often cited by papers focused on Coronary Interventions and Diagnostics (44 papers), Acute Myocardial Infarction Research (32 papers) and Cardiac Arrhythmias and Treatments (29 papers). Bryan P. Yan collaborates with scholars based in Hong Kong, China and Australia. Bryan P. Yan's co-authors include Gary Tse, Yat‐Yin Lam, Cheuk‐Man Yu, Yuan‐Ting Zhang, Yat‐Yin Lam, Carmen C. Y. Poon, Y.W. Chan, Kevin Ka‐Ho Kam, Gabriel Wai‐Kwok Yip and Yali Zheng and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Bryan P. Yan

198 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan P. Yan Hong Kong 39 3.0k 1.4k 778 646 484 208 5.0k
Antonis S. Manolis Greece 37 5.3k 1.8× 1.1k 0.8× 432 0.6× 867 1.3× 396 0.8× 329 7.5k
Domingo A. Pascual‐Figal Spain 46 4.2k 1.4× 1.8k 1.3× 554 0.7× 865 1.3× 739 1.5× 304 7.3k
Lino Gonçalves Portugal 28 3.4k 1.1× 1.4k 1.0× 312 0.4× 848 1.3× 371 0.8× 321 5.1k
Myeong‐Chan Cho South Korea 40 4.4k 1.5× 1.7k 1.2× 290 0.4× 652 1.0× 445 0.9× 329 6.2k
Dong‐Ju Choi South Korea 41 4.3k 1.4× 1.7k 1.2× 347 0.4× 642 1.0× 821 1.7× 345 6.6k
Ju Han Kim South Korea 36 2.8k 0.9× 1.9k 1.4× 270 0.3× 689 1.1× 726 1.5× 492 5.6k
Bart Mertens Netherlands 34 1.3k 0.4× 813 0.6× 606 0.8× 439 0.7× 562 1.2× 143 3.4k
Franz Weidinger Austria 33 2.2k 0.7× 1.3k 0.9× 244 0.3× 640 1.0× 506 1.0× 122 4.2k
Darryl P. Leong Canada 40 3.3k 1.1× 841 0.6× 291 0.4× 473 0.7× 488 1.0× 181 5.6k
Katerina Κ. Naka Greece 33 2.1k 0.7× 1.1k 0.8× 410 0.5× 379 0.6× 752 1.6× 192 4.2k

Countries citing papers authored by Bryan P. Yan

Since Specialization
Citations

This map shows the geographic impact of Bryan P. Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan P. Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan P. Yan more than expected).

Fields of papers citing papers by Bryan P. Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan P. Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan P. Yan. The network helps show where Bryan P. Yan may publish in the future.

Co-authorship network of co-authors of Bryan P. Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan P. Yan. A scholar is included among the top collaborators of Bryan P. Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan P. Yan. Bryan P. Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yan, Bryan P., et al.. (2025). Cardiovascular Safety of COVID-19 Treatments: A Disproportionality Analysis of Adverse Event Reports from the WHO VigiBase. Infectious Diseases and Therapy. 14(10). 2445–2463. 1 indexed citations
3.
So, Chak-Yu, A. Lai, Kevin Ka‐Ho Kam, et al.. (2025). Initial Real-World Experience of Tricuspid Transcatheter Edge-to-Edge Repair in Asia. JACC Asia. 6(1). 16–23.
4.
Chan, Joseph Yat‐Sun, et al.. (2025). Effect of Pulsed-Field Ablation on Human Coronary Arteries. JACC. Clinical electrophysiology. 11(7). 1478–1488. 5 indexed citations
6.
Chan, Joseph Yat‐Sun, et al.. (2024). Aveir VR real-world performance and chronic pacing threshold prediction using mapping and fixation electrical data. EP Europace. 26(3). 8 indexed citations
7.
Pak, Hui‐Nam, Kenichi Hiroshima, Takanori Yamaguchi, et al.. (2024). High‐density mapping in catheter ablation for atrial fibrillation in Asia Pacific region: An observational study. Journal of Arrhythmia. 41(1). e13168–e13168.
8.
Chan, Joseph Yat‐Sun, et al.. (2024). Personalized cardiac resynchronization therapy guided by real-time electrocardiographic imaging for patients with non–left bundle branch block. Heart Rhythm. 21(7). 1047–1056. 3 indexed citations
9.
Qi, Yuan, et al.. (2023). Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19. PLoS ONE. 18(1). e0280280–e0280280. 10 indexed citations
10.
Ng, Pauline Yeung, et al.. (2023). Clinical Outcomes of Left Atrial Appendage Occlusion Versus Switch of Direct Oral Antcoagulant in Atrial Fibrillation: A Territory‐Wide Retrospective Analysis. Journal of the American Heart Association. 12(20). e029421–e029421. 3 indexed citations
11.
Verheye, Stefan, Adrian Włodarczak, Piero Montorsi, et al.. (2020). BIOSOLVE‐IV‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients. Catheterization and Cardiovascular Interventions. 98(1). E1–E8. 58 indexed citations
12.
Yu, Doris Sau Fung, et al.. (2019). The effects and cost‐effectiveness of an empowerment‐based self‐care programme in patients with chronic heart failure: A study protocol. Journal of Advanced Nursing. 75(12). 3740–3748. 9 indexed citations
13.
Tan, GuangMing, et al.. (2019). PROGNOSTIC NUTRITIONAL INDEX AS A PREDICTOR OF PROGNOSIS IN PATIENTS WITH CRITICAL LIMB ISCHEMIA WHO UNDERWENT ENDOVASCULAR REVASCULARIZATION THERAPY. Journal of the American College of Cardiology. 73(9). 2064–2064. 2 indexed citations
14.
Cheng, Isaac T, Qing Shang, Edmund K. Li, et al.. (2018). Effect of Achieving Minimal Disease Activity on the Progression of Subclinical Atherosclerosis and Arterial Stiffness: A Prospective Cohort Study in Psoriatic Arthritis. Arthritis & Rheumatology. 71(2). 271–280. 26 indexed citations
15.
Carvalho, Leonardo Pinto de, Sock Hwee Tan, Zhiqun Tang, et al.. (2018). Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction. JACC Basic to Translational Science. 3(2). 163–175. 69 indexed citations
16.
Lowres, Nicole, David Fitzmaurice, Richard Hobbs, et al.. (2017). Abstract 20082: Guideline-based Screening for Atrial Fibrillation: Analysis of Yield and Stroke Risk. Circulation. 2 indexed citations
17.
Yeo, Jie Ming, et al.. (2017). Isolated heart models for studying cardiac electrophysiology: a historical perspective and recent advances. Journal of Basic and Clinical Physiology and Pharmacology. 28(3). 191–200. 14 indexed citations
18.
Ho, Jason, et al.. (2012). Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong. Clinical Cardiology. 35(12). 31 indexed citations
19.
Lu, K., Bryan P. Yan, Andrew E. Ajani, et al.. (2011). Impact of Concomitant Heart Failure on Outcomes in Patients Undergoing Percutaneous Coronary Interventions: Analysis of the Melbourne Interventional Group Registry. European Journal of Heart Failure. 13(4). 416–422. 6 indexed citations
20.
Lim, H., Omar Farouque, Nick Andrianopoulos, et al.. (2009). Survival of Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction Complicated by Cardiogenic Shock. JACC: Cardiovascular Interventions. 2(2). 146–152. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026